Grace Therapeutics News and Activities

Grace Therapeutics is a company listed under the stock ticker ACST (CA).

Acquisition, funding and merger involving Grace Therapeutics.

• Acasti Pharma will change its company name to Grace Therapeutics on Oct 25, 2024. (posted on October 27 2024).

View the org chart displaying its 8 main executives

Most searched biographies at Grace Therapeutics

• Prashant Kohli, Chief Executive Officer and Director
• Vimal Kavuru, Chairman of the Board
• Brian Davis, Director

Popular executive movements at Grace Therapeutics

• Carrie D'Andrea, Vice President, Clinical Operations, has left the company  (posted on June 8 2026).

Create your alert
to follow the executive moves at Grace Therapeutics.

Grace Therapeutics has 1,914 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Aurobindo has announced the acquisition of Lannett  (posted on June 26 2026).
• Merck has announced the acquisition of Bio-Techne  (posted on June 25 2026).
• Eli Lilly has acquired Centessa Pharmaceuticals (posted on June 24 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Grace Therapeutics

• 14th Annual LifeSci Partners Corporate Access Event
• Grace Therapeutics to Participate in Upcoming Investor Events January 2025
• Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference
• Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update
• Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024
• Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104
• Acasti to Present at the Life Sciences Investor Forum
• Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
• Acasti Announces First Fiscal Quarter 2025 Financial Results, Provides Business Update
• Acasti Announces Year-End 2024 Financial Results, Provides Business Update
• View more press releases Close

Social media about Grace Therapeutics

• Grace Therapeutics on Wikipedia, Google News & Yahoo Finance
• Grace Therapeutics on LinkedIn, X (Twitter) & YouTube